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The chloroquine-potentiating activities of thé Strychnos myrtoides alkaloids strychnobrasiline
and malagashanine has been demonstrated in vitro and in vivo by Rasoanaivo et al. in 1994
[1]. In thé continuation of our search for new antiplasmodial indole alkaloids [2] and with thé
aim of finding new resistance-modifiers agents, eight naturally occurring monoindole
alkaloids (icajine, strychnobrasiline, isoretuline, retuline, vomicine, novacine, holstiine and
dolichantoside) were evaluated in vitro for their ability to inhibit Plasmodium falciparum
growth and, in drug combination, to reverse thé résistance of a chloroquine-resistant strain of
Plasmodium falciparum. None of thèse indole alkaloids has significant intrinsic
antiplasmodial activity (ICs» > 10 pM or 5 ug/ml). Nevertheless, three alkaloids (icajine,
isoretuline and strychnobrasiline) reverse chloroquine résistance at concentrations between
2.5 and 25 ug/ml (IF of 12.82 for isoretuline on W2 strain). The Interaction Factor (IF)
equals 2, <2, or>2 for additive, antagonistic or synergistic effects of alkaloids on chloroquine
inhibition, respectively. Icajine and isoretuline were also assessed in vitro for their
mefloquine potentiating activity on a mefloquine-resistant strain of Plasmodium falciparum.
Only icajine proved to be synergistic with mefloquine (IF = 15.38).
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